Sign in Subscribe
COVID-19

FDA Approves Updated COVID-19 Vaccines as US Seeks to Boost Protection Against Latest Coronavirus Strains

Strategic Insights

— 2 min read

The US Food and Drug Administration has approved updated COVID-19 vaccines from Moderna and Pfizer-BioNTech, aiming to provide enhanced protection against the latest coronavirus strains and prevent hospitalizations this fall and winter. This decision marks a shift towards treating fall COVID-19 vaccine updates like annual flu shots. The Centers for Disease Control and Prevention must now issue recommendations on who should receive the updated shots, with vaccinations potentially starting later this week. The new vaccines target the omicron variant XBB.1.5, which is no longer dominant but still offers good cross-protection against current COVID-19 strains.

Key Takeaways:

  • The FDA has approved updated COVID-19 vaccines from Moderna and Pfizer-BioNTech for use in the US.
  • The new vaccines are designed to provide enhanced protection against the latest coronavirus strains and prevent hospitalizations.
  • The CDC advisory panel will issue recommendations on who should receive the updated shots on Tuesday.
  • Vaccinations could begin as early as this week, with both COVID-19 and flu shots available at the same visit.
  • The new vaccines target the omicron variant XBB.1.5, which is expected to provide good cross-protection against current COVID-19 strains.
  • People aged 5 and older can receive a single dose of the new vaccine, regardless of prior COVID-19 vaccination history.
  • Younger children may need additional doses depending on their COVID-19 vaccination and infection history.
  • The new vaccines are expected to be most protective against severe illness, hospitalization, and death, rather than mild infection.

Statistics:

  • COVID-19 hospitalizations have been rising since late summer, although not as much as this time last year (source: [Lauran Neergaard, The Associated Press]).
  • Protection against COVID-19 varies over time, with immunity waning after initial vaccinations and infections (source: [Lauran Neergaard, The Associated Press]).
  • The new vaccines target the omicron variant XBB.1.5, which is no longer dominant but still present in COVID-19 cases (source: [Lauran Neergaard, The Associated Press]).
  • The CDC advisory panel will issue recommendations on who should receive the updated shots on Tuesday (source: [Lauran Neergaard, The Associated Press]).
  • Vaccinations could begin as early as this week, with both COVID-19 and flu shots available at the same visit (source: [Lauran Neergaard, The Associated Press]).

Sources:

  • Lauran Neergaard, The Associated Press, "US approves updated COVID-19 vaccines to boost protection against latest strains" (no date provided).
  • The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group (no date provided).

Read more